Perception Neuroscience
ID: 6590504Developer of arketamine therapy intended to provide effective treatment solutions to serious psychiatric disorders.The company's lead product is the NMDA antagonist arketamine with the potential for rapid acting antidepressant activity and anti-suicidal effects.
Overview
Developer of arketamine therapy intended to provide effective treatment solutions to serious psychiatric disorders.The company's lead product is the NMDA antagonist arketamine with the potential for rapid acting antidepressant activity and anti-suicidal effects.
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Jo****** Sp*** |
|
- | |
| Te***** Ke*** | - | - |
Industries
Perception Neuroscience is active in the following industries: